Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

A Study of LY3502970 in Participants With Impaired and Normal Liver Function

NCT05882032 ·Status: COMPLETED ·Phase: PHASE1

Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis

NCT04399538 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD

NCT05281328 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment

NCT03309202 ·Status: COMPLETED ·Phase: PHASE1

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

NCT00529204 ·Status: TERMINATED ·Phase: PHASE2

A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.

NCT05857644 ·Status: COMPLETED ·Phase: PHASE1

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

NCT02231333 ·Status: COMPLETED ·Phase: NA

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

NCT06891365 ·Status: RECRUITING ·Phase: PHASE1

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

NCT05917938 ·Status: COMPLETED ·Phase: PHASE1

De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

NCT05808192 ·Status: COMPLETED

Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis

NCT03193502 ·Status: UNKNOWN ·Phase: PHASE3

A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease

NCT05308160 ·Status: UNKNOWN ·Phase: PHASE3

A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795

NCT04844450 ·Status: COMPLETED ·Phase: PHASE1

Acamprosate Safe to Use in Individuals With Liver Disease.

NCT04287920 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

NCT05364931 ·Status: COMPLETED ·Phase: PHASE2

Insulin Resistance in Non-alcoholic Fatty Liver Disease

NCT00252499 ·Status: TERMINATED ·Phase: NA

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

NCT03207425 ·Status: COMPLETED ·Phase: PHASE1

Somatostatin in Living Donor Liver Transplantation

NCT04107428 ·Status: UNKNOWN ·Phase: PHASE4

a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）

NCT07128797 ·Status: RECRUITING ·Phase: PHASE1

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

NCT02918929 ·Status: COMPLETED ·Phase: PHASE1

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

NCT04395950 ·Status: WITHDRAWN ·Phase: PHASE1

A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989

NCT04208386 ·Status: COMPLETED ·Phase: PHASE1

A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

NCT05098054 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD

NCT03950882 ·Status: COMPLETED ·Phase: PHASE1